Rong Zhou - 06 Mar 2023 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
EVP, Production Center
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
06 Mar 2023
Transactions value $
$0
Form type
4
Filing time
08 Mar 2023, 15:06:17 UTC
Previous filing
18 Mar 2022
Next filing
17 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Award $0 +15.1K +19.22% $0.00 93.8K 06 Mar 2023 Direct F1, F2
holding AMPH Common Stock 99.7K 06 Mar 2023 See footnote F3
holding AMPH Common Stock 5K 06 Mar 2023 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Award $0 +31.9K $0.00 31.9K 06 Mar 2023 Common Stock 31.9K $35.13 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 6, 2024.
F2 Includes 981 shares and 146 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively.
F3 The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.
F4 The shares are held of record by the reporting person's spouse.
F5 The shares subject to the option vest in four equal annual installments beginning on March 6, 2024.